Viewing Study NCT05847257



Ignite Creation Date: 2024-05-06 @ 6:57 PM
Last Modification Date: 2024-10-26 @ 2:58 PM
Study NCT ID: NCT05847257
Status: COMPLETED
Last Update Posted: 2023-05-06
First Post: 2023-04-10

Brief Title: Impact of Co Enzyme Q10 as Adjuvant Therapy to Letrozole on Spermiogram
Sponsor: Al-Mustansiriyah University
Organization: Al-Mustansiriyah University

Study Overview

Official Title: Impact of Co Enzyme Q10 as Adjuvant Therapy to Letrozole on Spermiogram and Sex Hormone in Iraqi Infertile Men A Comparative Study
Status: COMPLETED
Status Verified Date: 2023-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Worldwide infertility affects about 15 of reproductive-age couples In many cases infertility cant be treated new treatment options with promising value were involved in the recent clinical trials
Detailed Description: We will evaluate the impacts of adding coenzyme Q10 to letrozole on spermiogram and sex hormone in men diagnosed with idiopathic oligoastheno teratozoospermia iOAT syndrome

The study will include 67 patients which will be randomly separated into two groups Group A 29 patients will be treated with letrozole 25mg tablet orally twice a week Group B 38 patient will be treated with a combination of letrozole 25 mg tablet orally twice a week plus Co-Q10 400mg per day both groups complete treatment for three months Semen sample serum FSH estradiol E2 and testosterone T were analyzed at day one and at the end of one two and three months

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None